Dermatological problems in canines are one of the most common reasons for veterinary clinic visits, and some experts place the prevalence of pains such as Canine Atopic Dermatitis between 10% and 15% of the total canine population.
At Bioiberica we offer innovative solutions in the area of Dermatology, in line with our philosophy of offering innovative and scientifically-proven products with high added value.
Recent studies have shown that the alteration of the epidermal barrier is a central pathophysiological mechanism in atopic dermatitis. For a correct control of a patient with atopic dermatitis, it is essential to understand the pathogenic mechanisms and repair the epidermal barrier and its functionality.
Treatments with sphingolipids and nucleotides, administered topically or systemically respectively, have been shown to be one of the most effective and safe interventions in the for the epidermal barrier and in the control of the clinical signs associated with atopic dermatitis.
Go to Webinar